Q2 and FY consensus estimates
Estimates for Q2 and FY 2019/20 based on median.
| Q2 2019/20 | FY 2019/20 | |||||||
| DKKm | Low | Consensus | High | Low | Consensus | High | ||
| Revenue |
971 |
986 | 990 | 3,567 | 3,666 | 3,921 | ||
| Gross profit |
587 |
608 | 624 |
2,179 |
2,265 | 2,464 | ||
| Gross margin |
60.5% |
61.6% | 63.6% |
60.2% |
61.5% | 63.3% | ||
| EBIT before special items |
136 |
171 | 203 | 507 | 561 | 670 | ||
| EBIT margin before special items |
13.8% |
17.0% | 20.5% | 14.2% | 15.5% | 17.1% | ||
| Net profit |
83 |
122 | 144 | 296 | 365 | 448 | ||
| Net profit margin |
8.4% |
12.3% | 14.6% | 8.3% | 10.1% | 11.4% | ||
| Endoscopes sold (units) | N/A | 313,000 | N/A |
1,005,537 |
1,090,000 | 1,239,167 | ||
| Organic growth | N/A | 24% | N/A |
26% |
28% | 46% |
27 April 2020, based on estimates from 11 analysts.
